Achievable logoAchievable logo
USMLE/1
Sign in
Sign up
Purchase
Textbook
Support
How it works
Resources
Exam catalog
Mountain with a flag at the peak
Textbook
Introduction
1. Anatomy
2. Microbiology
3. Physiology
4. Pathology
5. Pharmacology
6. Immunology
7. Biochemistry
8. Cell and molecular biology
9. Biostatistics and epidemiology
10. Genetics
11. Behavioral science
Wrapping up
Achievable logoAchievable logo
4.7.1.8 Nephrolithiasis
Achievable USMLE/1
4. Pathology
4.7. Renal, endocrine and reproductive system
4.7.1. Renal system

Nephrolithiasis

3 min read
Font
Discuss
Share
Feedback

Nephrolithiasis (renal stones) is a common disorder of the urinary system. Several types of renal stones (calculi) can form, including calcium oxalate (most common), calcium phosphate, uric acid, cystine, and struvite stones.

Staghorn calculi are branched stones that extend into adjoining calyces. Struvite stones can form staghorn calculi.

Calcium oxalate stones often begin as deposits called Randall’s plaques in the loop of Henle. Calcium phosphate stones typically begin in the collecting ducts due to crystal deposition. Patients with cystinuria are predisposed to form cystine stones. Rarely, insoluble drugs such as indinavir, triamterene, and ephedrine can form stones.

Clinical features

It typically presents with renal colic that starts in the flank and moves down toward the genital area as the stone travels from the upper to the lower urinary tract. The pain is not affected by changes in body position.

Other common features include:

  • Nausea and vomiting
  • Sweating
  • Gross or microscopic hematuria
  • Urinary urgency and frequency

Symptoms are relieved once the stone passes into the bladder and is then passed in urine. Renal stones also predispose to urinary tract infection (UTI).

Risk factors and associations

The following conditions are associated with recurrent stones:

  • Distal renal tubular acidosis
  • Hyperparathyroidism
  • Hypercalciuria
  • Hyperuricosuria
  • Oxaluria
  • Cystinuria

Additional associations:

  • Excess vitamin C and a low-calcium diet can cause hyperoxaluria.
  • Myeloproliferative disorders or chemotherapy can cause hyperuricosuria.
  • Calcium supplements increase the risk of stone formation, especially when taken on an empty stomach.

Investigations

Preferred investigation is CT without contrast.

Other imaging options:

  • KUB can be used to visualize radio-opaque stones only.
  • Ultrasound is preferred as an initial investigation in children and pregnant women to avoid radiation exposure.

Stones > 10 mm in size do not pass spontaneously, while most stones < 5 mm in size are passed spontaneously in urine.

Management

General measures:

  • Increase fluid intake to keep urine dilute.
  • Use NSAIDs and narcotics to control pain.

Medical prevention and stone-specific measures:

  • Thiazides help prevent stone formation in patients with hypercalciuria by increasing calcium absorption in the proximal tubule.
  • Potassium citrate chelates calcium in urine and prevents calcium stone formation.
  • Cholestyramine helps prevent oxalate stone formation.

Medical expulsive therapy (for stones < 10 mm):

  • Doxazosin
  • Tamsulosin
  • Nifedipine

Procedures:

  • Extracorporeal shock wave lithotripsy (ESWL) can be used to break down larger stones.
  • Stones in the ureters and renal pelvis can be removed endoscopically by ureteroscopy.

In the presence of hydronephrosis, immediate treatment is needed to preserve renal function.

Stone analysis

Stones can be studied by X-ray crystallography and infrared spectroscopy to guide preventive measures.

Sign up for free to take 1 quiz question on this topic

All rights reserved ©2016 - 2026 Achievable, Inc.